Phase 2 Clinical Trial Results Show Potential to Shorten TB Treatment Time
Thuto Pulane, a TB survivor and participant in the NC-009 trial, at a follow-up appointment with Dr. William Brumskine, NC-009 […]
News
WHO Report Shows TB Gains, But Funding Gaps Threaten Momentum
TB Alliance is gratified to see clear progress against tuberculosis in the latest WHO Global TB Control Report. While TB
Digital First, Faster Access: How TB Alliance Is Using Tech to Speed BPaL/M to People Who Need It
For decades, breakthrough TB science has too often moved slowly from approval to those in need. In the roll out
TB Alliance Launches Upskill TB Platform in Collaboration with Indonesia’s Ministry of Health and RPRI Foundation
Digital Training Platform, Upskill TB, Strengthens Capacity to Deliver New DR-TB Treatments JAKARTA (October 9, 2025)—TB Alliance, in collaboration with
DR-TB Regimen Will Save 190,000+ Additional Lives and $1.29B by 2035
The six-month, all-oral BPaL/M regimens for the treatment of drug-resistant TB (DR-TB) are already changing the trajectory of DR-TB care
New Report Finds Investing in Global Health R&D Delivers Returns at Home and Abroad
The investment case for global health R&D is increasingly evidence-based. Impact Global Health’s new Ripple Effect analysis tracks what happens
New Study Finds Investing in Shorter, More Effective TB Treatment Pays Off
A new analysis, published in IJTLD Open, from South Africa and the Philippines further confirms that six-month, all-oral BPaL/M regimens
TB Alliance Welcomes WHO Prequalification of Lupin’s Pretomanid Product
NEW YORK (September 12, 2025)—Lupin Limited, a leading pharmaceutical company headquartered in India, has been granted prequalification by the World
TB Alliance Appoints Dr. Soraya Madani as Senior Vice President, Program and Alliance Management
New York, NY (August 29, 2025) – TB Alliance announced the appointment of Dr. Soraya Madani as Senior Vice President,
TB Alliance Congratulates Dr. Kathleen Schostack on Her Retirement
As Senior Vice President of Program and Alliance Management, Dr. Schostack played a vital role in advancing TB drug development